PillRx only · Spray · Nasal
Desmopressin Acetate
Desmopressin Acetate
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$9.821
Latest avg · Jul 22, 2026
+5%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
5.1K
Rx · 2026 Q1
44K
Units dispensed
-28%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Apotex Corp. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 8, 2026RECALLRecall (Class II): Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, C…
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners. — Recalling firm: Apotex Corp. — U.S.A. Nationwide
- Mar 12, 2021SHORTAGEDrug shortage: Desmopressin Acetate Spray (Apotex Corp.)
Desmopressin Acetate Spray — reported in shortage by Apotex Corp.. Therapeutic category: Hematology.